Alexion and Sema4 partner in rare disease diagnostics

Alexion has partnered with Sema4 to leverage their shared experience in data science and systems biology to accelerate rare disease diagnosis and therapeutic discovery. This new partnership will combine Alexion's rare disease SmartPanel analytics with Sema4's sequencing and genomic interpretation to further enable novel diagnostic and therapeutic insights into rare diseases. The world-class sequencing capabilities at Sema4 coupled with Alexion's SmartPanel analytics will enable a comprehensive evaluation of a patient's genome to uncover pathogenic mutations linked to rare diseases," said John Reynders, PhD, vice president of Data Sciences, Genomics, and Bioinformatics at Alexion. This collaboration will help accelerate an accurate diagnosis for patients with rare genetic diseases and reduce the multi-year process that many families face before receiving a diagnosis.